VR Logo

Dishman Pharmaceuticals & Chemicals Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

48 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

Financial Year Full AR Chairman's
Speech
Director's
Report
Management
Discussion
Corporate
Governance
Auditor's
Report
Notes to
Accounts
2017 download pdf full AR
2016 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes
2015 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes
2014 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes
2013 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes
2012 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes
2011 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes
2010 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes
2009 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes
2008 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes
2007 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes
2006 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes
2005 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes
2004 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes

About The Company

Business: Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids;

Incorporated: 1983

Chairman: Janmejay R Vyas

Managing Director: Arpit J Vyas

Group: Dishman Pharma

Listing:

Headquarters: --

Website:--

Key Facts

Market cap: R --

Revenue (TTM): R --

Earnings (TTM): R --

: R --

: R --

Promoters' ownership: --

Liquidity:

52 Week range: R -- - --

Face value: R--

Shares outstanding: --

10 Years Aggregate:

  • CFO: 1,921.71 Cr
  • EBITDA: 2,503.24 Cr
  • Net Profit: 1,115.59 Cr

Stock Performance

Time Period Dishman Pharma & Chem S&P BSE Mid Cap S&P BSE Healthcare
YTD--42.5015.64
1 month--1.59-5.01
3 months--10.98-4.72
1 Year--71.7227.46
3 Years--22.3319.96
5 Years--13.448.93
10 Years--15.3715.49
As on 22-Oct-2021
Year Dishman Pharma & Chem S&P BSE Mid Cap S&P BSE Healthcare
201628.267.97-12.88
2015147.637.4315.06
201430.3054.6947.43
2013-13.96-5.7322.55
2012208.1938.2738.28
2011-76.28-34.19-12.83
2010-33.9816.1534.19